Azenta, Inc. (AZTA) Analyst/Investor Day Transcript
BRBR, AZTA and BRDCY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2025.
Azenta, Inc. ( AZTA ) Q4 2025 Earnings Call November 21, 2025 8:30 AM EST Company Participants Yvonne Perron - Vice President of Financial Planning & Analysis and Investor Relations John P. Marotta - President, CEO & Director Lawrence Lin - Executive VP & CFO Conference Call Participants David Saxon - Needham & Company, LLC, Research Division Steven Etoch - Stephens Inc., Research Division Andrew Cooper - Raymond James & Associates, Inc., Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Jacqueline Kisa - TD Cowen, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Presentation Operator Greetings, and welcome to the Azenta Q4 2025 Financial Results.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | John P. Marotta CEO | XDUS Exchange | US1143401024 ISIN |
| US Country | 3,000 Employees | 2 Dec 2021 Last Dividend | - Last Split | - IPO Date |
Azenta, Inc. offers specialized biological and chemical compound sample management and exploration solutions tailored for the life sciences market globally, including regions such as North America, Africa, China, the United Kingdom, the rest of Europe, and the Asia Pacific. With operations in two key segments - Life Sciences Products and Life Sciences Services - Azenta caters to a wide audience in pharmaceuticals, biotech, healthcare, clinical research, and academic sectors. It has transformed from its original name, Brooks Automation, Inc., reflecting its focus and expertise in life sciences since its establishment in 1978. Based in Burlington, Massachusetts, Azenta has evolved to become a pivotal provider of comprehensive services and products for managing, preserving, and analyzing biological samples and compounds for the life sciences industry.
These include advanced storage facilities designed to automate the management of samples at cold temperatures, ensuring their preservation and integrity for long-term research and analysis needs.
A wide range of essential laboratory consumables and instruments, including vials, tubes, polymerase chain reaction plates, and devices supporting various workflows, all tailored to enhance the efficiency of life sciences research.
Specially designed devices for the controlled thawing of frozen samples to preserve their biological activity and integrity for further analysis or experimentation.
Offers a suite of solutions for the storage and transport of temperature-sensitive samples, ensuring they remain uncompromised throughout their journey and storage period.
Comprehensive genomic analysis offerings, including gene sequencing and synthesis services that support the research, discovery, and development processes in life sciences.
Services encompassing both on-site and off-site sample storage, cold chain logistics, sample transport, collection relocation, bio-processing solutions, and disaster recovery. Azenta also provides project management and consulting services, underscoring its role as a versatile partner in biospecimen management.
Reliable procurement of biospecimens tailored to the specific needs of research, development, and clinical studies, facilitating advancements in healthcare and biotechnology.